新华制药间苯三酚注射液获药品注册证书,有望开拓新市场

中访网数据
Dec 30, 2025

中访网数据山东新华制药股份有限公司近日宣布,其申报的间苯三酚注射液已获得国家药品监督管理局核准签发的《药品注册证书》。该药品注册分类为化学药品4类,规格为4ml:40mg,批准文号为国药准字H20256347。本品主要用于治疗消化系统、胆道功能障碍以及泌尿系统、妇科相关的急性痉挛性疼痛。根据市场统计数据,2024年该药品在中国公立医疗机构的销售额约为人民币9亿元,且已被纳入《国家基本医疗保险、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10